Literature DB >> 27189764

Involvement of nigral oxytocin in locomotor activity: A behavioral, immunohistochemical and lesion study in male rats.

Laura Angioni1, Cristina Cocco1, Gian-Luca Ferri1, Antonio Argiolas2, Maria Rosaria Melis2, Fabrizio Sanna3.   

Abstract

Oxytocin is involved in the control of different behaviors, from sexual behavior and food consumption to empathy, social and affective behaviors. An imbalance of central oxytocinergic neurotransmission has been also associated with different mental pathologies, from depression, anxiety and anorexia/bulimia to schizophrenia, autism and drug dependence. This study shows that oxytocin may also play a role in the control of locomotor activity. Accordingly, intraperitoneal oxytocin (0.5-2000μg/kg) reduced locomotor activity of adult male rats. This effect was abolished by d(CH2)5Tyr(Me)(2)-Orn(8)-vasotocin, an oxytocin receptor antagonist, given into the lateral ventricles at the dose of 2μg/rat, which was ineffective on locomotor activity. Oxytocin (50-200ng/site) also reduced and d(CH2)5Tyr(Me)(2)-Orn(8)-vasotocin (2μg/site) increased locomotor activity when injected bilaterally into the substantia nigra, a key area in the control of locomotor activity. Conversely, the destruction of nigral neurons bearing oxytocin receptors by the recently characterized neurotoxin oxytocin-saporin injected into the substantia nigra, increased basal locomotor activity. Since oxytocin-saporin injected into the substantia nigra caused a marked reduction of neurons immunoreactive for tyrosine hydroxylase (e.g., nigrostriatal dopaminergic neurons) and for vesicular glutamate transporters VGluT1, VGluT2 and VGluT3 (e.g., glutamatergic neurons), but not for glutamic acid decarboxylase (e.g., GABAergic neurons), together these findings suggest that oxytocin influences locomotor activity by acting on receptors localized presynaptically in nigral glutamatergic nerve terminals (which control the activity of nigral GABAergic efferent neurons projecting to brain stem nuclei controlling locomotor activity), rather than on receptors localized in the cell bodies/dendrites of nigrostriatal dopaminergic neurons.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dopamine; Glutamic acid; Locomotor activity; Oxytocin; Oxytocin-saporin; Substantia nigra

Mesh:

Substances:

Year:  2016        PMID: 27189764     DOI: 10.1016/j.yhbeh.2016.05.012

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  7 in total

1.  Role of oxytocin in the ventral tegmental area in social reinforcement.

Authors:  Johnathan M Borland; Kymberly N Grantham; Lauren M Aiani; Kyle J Frantz; H Elliott Albers
Journal:  Psychoneuroendocrinology       Date:  2018-05-21       Impact factor: 4.905

2.  Biased Oxytocinergic Modulation of Midbrain Dopamine Systems.

Authors:  Lei Xiao; Michael F Priest; Jordan Nasenbeny; Ting Lu; Yevgenia Kozorovitskiy
Journal:  Neuron       Date:  2017-06-29       Impact factor: 17.173

3.  Effect of sex and autism spectrum disorder on oxytocin receptor binding and mRNA expression in the dopaminergic pars compacta of the human substantia nigra.

Authors:  Sage S Frehner; Kip T Dooley; Michelle C Palumbo; Aaron L Smith; Mark M Goodman; Karen L Bales; Sara M Freeman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2022-07-11       Impact factor: 6.671

4.  Oxytocin attenuates phencyclidine hyperactivity and increases social interaction and nucleus accumben dopamine release in rats.

Authors:  Shivali Kohli; Madeleine V King; Stuart Williams; Adele Edwards; Theresa M Ballard; Lucinda J Steward; Daniella Alberati; Kevin C F Fone
Journal:  Neuropsychopharmacology       Date:  2018-08-07       Impact factor: 7.853

Review 5.  The Hypothalamic-Pituitary Axis and Autoantibody Related Disorders.

Authors:  Cristina Cocco; Carla Brancia; Giulia Corda; Gian-Luca Ferri
Journal:  Int J Mol Sci       Date:  2017-11-03       Impact factor: 5.923

6.  The Autism Palette: Combinations of Impairments Explain the Heterogeneity in ASD.

Authors:  Ábel Fóthi; Latha Soorya; András Lőrincz
Journal:  Front Psychiatry       Date:  2020-12-02       Impact factor: 4.157

Review 7.  Oxytocin as an Anti-obesity Treatment.

Authors:  JingJing Niu; Jenny Tong; James E Blevins
Journal:  Front Neurosci       Date:  2021-10-13       Impact factor: 4.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.